Revisiting Immunity

NAPWA helps to promote immune-based therapies by Chael Needle At the International AIDS Conference last June, the AIDS Institute and the National Association of People with AIDS...

REPRIEVE Study

Protecting One's Heart The REPRIEVE study aims to prevent cardiovascular disease by Chael Needle As people are living longer with HIV, researchers have been increasingly attending to...

Treatment as Prevention

LifeGuide A community perspective on PrEP delves into its pros & cons by Jeannie Gibbs Post-exposure prophylaxis (PrEP) is the provision of antiretrovirals (ARVs) to HIV-negative...

Restoring Immune Balance

Chronic inflammation means the immune system is imbalanced—a natural immune response has persisted, or immune regulation is not working properly. Research has shown that...

An HIV Injectable Regimen Comes of Age

Without the Pill Box? The First Long-Acting Injectable Regimen for Individuals Living with HIV Comes of Age by Mel Baker A funny thing happened on the way to...

TANGO Study Starts

In February 2018, ViiV Healthcare announced the start of a forty-eight-week phase III study designed to determine whether adults with HIV-1 who have achieved...

First Line

A treatment for advanced HIV-associated Kaposi’s sarcoma is relaunched by Chael Needle Newly acquired by Galen from Gilead Sciences, DaunoXome (daunorubicin citrate liposome injection) is an...

The Early Days

LifeGuide Dr. C. Everett Koop Revisits a Time When Neither Treatment nor Testing Existed by Chael Needle Knowing he had to face the micromanaging tendencies and...

Editing Genes for a Cure

Close to the Edit A functional cure candidate modifies genes to create HIV-resistant cells by Chael Needle Gary Blick, MD, AAHIVS, Medical & Research Director of CIRCLE...

Bathroom Reading

A newly approved anti-diarrheal agent seeks to counter side effects of HAART by Chael Needle Recently, the FDA approved Fulyzaq (crofelemer) 125 mg delayed-release tablets for...

LATEST POSTS

We Need to Bring Immune-Based HIV Therapies Off of the Sidelines

Dreaming of the Cells We Had We Need to Bring Immune-Based Therapies Off of the Sidelines by Jeannie Wraight For most people living with HIV, antiretrovirals (ARVs)...